Genmab A/S Files 6-K on Share Transactions
Ticker: GNMSF · Form: 6-K · Filed: Jun 17, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, securities-transactions, regulatory-filing
Related Tickers: GMAB
TL;DR
Genmab 6-K filed: Share and linked security transactions announced June 17, 2025.
AI Summary
On June 17, 2025, Genmab A/S filed a Form 6-K, incorporating by reference a company announcement dated June 17, 2025, regarding transactions with its shares and linked securities. This filing is deemed part of Genmab's existing S-8 registration statements.
Why It Matters
This filing provides transparency into recent dealings with Genmab's shares and related securities, which can be important for investors monitoring insider activity or corporate actions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share transactions and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- June 17, 2025 (date) — Date of Company Announcement
- 001-38976 (other) — SEC File Number
- 333-232693 (other) — S-8 Registration Statement File Number
- 333-253519 (other) — S-8 Registration Statement File Number
- 333-262970 (other) — S-8 Registration Statement File Number
- 333-277273 (other) — S-8 Registration Statement File Number
- 333-284876 (other) — S-8 Registration Statement File Number
FAQ
What type of transactions are disclosed in the June 17, 2025 company announcement?
The announcement pertains to transactions with shares and linked securities in Genmab A/S.
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer and incorporates by reference a company announcement regarding share transactions.
Which registration statements does this 6-K filing get incorporated into?
This filing is incorporated by reference into Genmab A/S's registration statements on Form S-8, specifically File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What is the filing date of this Form 6-K?
The filing date is June 17, 2025.
What is Genmab A/S's principal executive office address?
Genmab A/S's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 17, 2025 regarding GENMAB A/S (GNMSF).